Mn Wealth Advisors, LLC Novo Nordisk A S Transaction History

Mn Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	BUY	$69.3 - $90.95 $7,415 - $9,731	107 Added 3.85%	2,889 $201 Million
Q4 2024 Jan 30, 2025	SELL	$85.0 - $120.04 $17,510 - $24,728	-206 Reduced 6.89%	2,782 $239 Million
Q3 2024 Oct 15, 2024	SELL	$119.07 - $145.42 $6,191 - $7,561	-52 Reduced 1.71%	2,988 $356 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $266,851 - $320,568	3,040 New	3,040 $315 Million

1,686

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Mn Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mn Wealth Advisors, LLC with notifications on news.